Parathyroid hormone and parathyroid hormone-related protein analogs show promise for osteoporosis, but, for now, they’re reserved for the most...
MADRID – Investigational bone-building drug looks promising, but safety concerns emerge.
From the Editor
Yes. For postmenopausal women aged 50 to 59 years, hormone therapy reduces the risk of death.
News for Your Practice
Address the benefit–risk profile of hormonal and nonhormonal treatments to help women care for their vasomotor symptoms and GSM, say two menopause...
VANCOUVER – Age and previous disease severity are important factors in weighing whether to prescribe hormone therapy for postmenopausal women with...
With more than 1 billion menopausal women likely to be affected by vulvovaginal atrophy worldwide by 2025, the need for effective remedies is...
The recommendations do not apply to women using hormone therapy to manage their menopause symptoms.
Data suggest that several years of systemic hormone therapy are safe in mutation carriers who have intact breasts and no personal history of...
SAN DIEGO – Endometrial cancer rates spiked between 2006 and 2014, according to a large analysis of national data.
The latest guidance on safe use of menopausal hormone therapy
From the Journals
Even though well-designed, randomized controlled trials amply demonstrate the effectiveness of bisphosphonates in preventing fractures,...